Carregant...
The role of MicroRNA in castration resistant prostate cancer
INTRODUCTION: Castration resistant prostate cancer (CRPC) has a historically low median survival rate but recent advances and discoveries in micro RNAs (miRNAs) have opened the potential for new prognostication modalities to enhance therapeutic success. As new chemotherapies and immunotherapies are...
Guardat en:
| Publicat a: | Urol Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570565/ https://ncbi.nlm.nih.gov/pubmed/24935732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.11.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|